Cemented vs. Cementless Hemiarthroplasty for Femoral Neck Fractures
This commentary comes from guest contributor Matthew Deren, MD, in response to a recent study in The New England Journal […]
Improving Our Ability to Predict Discharge Disposition After Primary Total Hip and Knee Arthroplasty
The majority of patients who undergo primary total hip arthroplasty (THA) and total knee arthroplasty (TKA) are discharged to home
Elite Reviewer Spotlight: Dirk Jan F. Moojen
JBJS is pleased once again to highlight our Elite Reviewers. The Elite Reviewers Program recognizes our best reviewers for their
Impending vs. Completed Pathological Long-Bone Fractures: What Are the Decision Points?
When patients present with identified bone metastases, a known primary diagnosis, and pain, the orthopaedic surgeon is nearly always contacted.
Elite Reviewer Spotlight: Michael W. Chapman
JBJS is pleased once again to highlight our Elite Reviewers. The Elite Reviewers Program recognizes our best reviewers for their
Continuation versus discontinuation of anti-rheumatic biologics during the perioperative period: What does the evidence support?
February 17, 2022 – For patients with rheumatic arthritis and other chronic inflammatory diseases, discontinuing biologic disease-modifying anti-rheumatic drugs (bDMARDs)
Elite Reviewer Spotlight: Thomas J. Blumenfeld
JBJS is pleased once again to highlight our Elite Reviewers. The Elite Reviewers Program recognizes our best reviewers for their
Elite Reviewer Spotlight: Roger Cornwall
JBJS is pleased once again to highlight our Elite Reviewers. The Elite Reviewers Program recognizes our best reviewers for their
New Deputy Editor Spotlight: Antonia Chen
JBJS recently welcomed Antonia F. Chen, MD, MBA as Deputy Editor for Adult Reconstruction. Dr. Chen is an orthopaedic surgeon